Listed medical device company Fisher & Paykel Healthcare has provided long-awaited revenue and net profit guidance for the first half of the 2023 financial year, and it indicates the Covid hangover is ongoing.
At current exchange rates, and assuming trading conditions over the first four months
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
